Abstract PS13-34: Differential efficacy of pegfilgrastim (Peg) in patients (pts) with breast cancer (BC) versus other cancer types for the prevention of docetaxel (Doc) chemotherapy-induced neutropenia (CIN) - KIVIRID

Abstract PS13-34: Differential efficacy of pegfilgrastim (Peg) in patients (pts) with breast cancer (BC) versus other cancer types for the prevention of docetaxel (Doc) chemotherapy-induced neutropenia (CIN)

Authors: Douglas W. Blayney, Greg Ginn, Lan Huang, Ramon Mohanlal

Published: 2021-02-15

DOI: 10.1158/1538-7445.sabcs20-ps13-34

Source: Full article

Abstract

Abstract